Skip to main content Back to Top
Advertisement

1/14/2020

Mupirocin Calcium 2% Cream

Products Affected - Description

    • Bactroban topical cream, GlaxoSmithKline, 2%, 15 gm tube, 1 count, NDC 00029-1527-22
    • Bactroban topical cream, GlaxoSmithKline, 2%, 30 gram tube, 1 count, NDC 00029-1527-25
    • Mupirocin calcium topical cream, Glenmark, 2%, 15 gram tube, 1 count, NDC 68462-0564-17

Reason for the Shortage

    • GlaxoSmithKline is looking for an alternative supply source.
    • Glenmark did not provide a reason for the shortage.
    • Prasco discontinued mupirocin calcium 2% cream in February 2016.

Available Products

    • Mupirocin calcium topical cream, Glenmark, 2%, 30 gram tube, 1 count, NDC 68462-0564-35

Estimated Resupply Dates

    • Glenmark has mupirocin calcium 2% cream in 15 gram tubes on back order and the company cannot estimate a release date.
    • GlaxoSmithKline has Bactroban 2% cream in 15 gram and 30 gram sizes on long-term back order and the company cannot estimate a release date.

Updated

Updated January 14, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. Created September 4, 2015 by Jane Chandramouli, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins